UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

Neuroendocrine differentiation is an independent prognostic factor in chemotherapy‐treated nonsmall cell lung carcinoma

Cancer, 1996-04, Vol.77 (7), p.1284-1291

1996

Volltextzugriff (PDF)

The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: Results of a North Central Cancer treatment group Phase III study

Cancer, 1998-03, Vol.82 (6), p.1037-1048

1998

Volltextzugriff (PDF)

Findings from the phase I clinical trials of CX-4945, an orally available inhibitor of CK2

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.3087-3087

2011

Volltextzugriff (PDF)

Phase II trial of topotecan for the treatment of mesothelioma

American journal of clinical oncology, 1998-12, Vol.21 (6), p.610-613

1998

Volltextzugriff (PDF)

Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trial

Journal of clinical oncology, 1995-08, Vol.13 (8), p.2012-2015

1995

Volltextzugriff (PDF)

Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer

American journal of clinical oncology, 1999-02, Vol.22 (1), p.15-17

1999

Volltextzugriff (PDF)

A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2000-05, Vol.28 (2), p.157-162

2000

Volltextzugriff (PDF)

Etiologic considerations in superior vena cava syndrome

Mayo Clinic proceedings, 1981-07, Vol.56 (7), p.407

1981

Volltextzugriff (PDF)

Treatment of limited-stage small-cell lung cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide: a randomized trial of the North Central Cancer Treatment Group

Journal of clinical oncology, 1990-01, Vol.8 (1), p.33-38

1990

Volltextzugriff (PDF)

A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinoma

Cancer, 1992-11, Vol.70 (9), p.2281-2287

1992

Volltextzugriff (PDF)

Phase II study of combined levamisole with recombinant interleukin-2 in patients with advanced malignant melanoma

American journal of clinical oncology, 1997-10, Vol.20 (5), p.490-492

1997

Volltextzugriff (PDF)

A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma

Journal of clinical oncology, 1985-12, Vol.3 (12), p.1624-1631

1985

Volltextzugriff (PDF)

Combined levamisole with recombinant interleukin-2 (IL-2) in patients with advanced renal cell carcinoma: A phase II study

American journal of clinical oncology, 1998-04, Vol.21 (2), p.139-141

1998

Volltextzugriff (PDF)

Evaluation of intravenous 6-thioguanine as first-line chemotherapy in women with metastatic breast cancer

American journal of clinical oncology, 1997-02, Vol.20 (1), p.69-72

1997

Volltextzugriff (PDF)

Advanced Colorectal Adenocarcinoma: Treatment With Amonafide

JNCI : Journal of the National Cancer Institute, 1994-06, Vol.86 (12), p.944-945

1994

Volltextzugriff (PDF)

Prospective phase I evaluation of radiation therapy, 5-fluorouracil, and levamisole in locally advanced gastrointestinal cancer

International journal of radiation oncology, biology, physics, 1994-01, Vol.28 (2), p.439-443

1994

Volltextzugriff (PDF)

A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin

JAMA : the journal of the American Medical Association, 1985-04, Vol.253 (14), p.2061

1985

Volltextzugriff (PDF)

Randomized trial of doxorubicin alone or combined with vincristine and mitomycin C in women with metastatic breast cancer

American journal of clinical oncology, 1989-12, Vol.12 (6), p.474-480

1989

Volltextzugriff (PDF)

A phase III clinical trial comparing the combination cyclophosphamide, adriamycin, cisplatin with cyclophosphamide, 5-fluorouracil, prednisone in patients with advanced breast cancer

Journal of clinical oncology, 1984-11, Vol.2 (11), p.1260-1265

1984

Volltextzugriff (PDF)

Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast cancer

Journal of clinical oncology, 1988-05, Vol.6 (5), p.825-831

1988

Volltextzugriff (PDF)

Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancer

Cancer, 1989-05, Vol.63 (10), p.1931-1937

1989

Volltextzugriff (PDF)

Evaluation of fludarabine phosphate in patients with recurrent glioma

American journal of clinical oncology, 1988-10, Vol.11 (5), p.586-588

1988

Volltextzugriff (PDF)

A controlled evaluation of combined 5-fluorouracil, doxorubicin, and mitomycin C (FAM) for the treatment of advanced non-small-cell lung cancer

Journal of clinical oncology, 1985-06, Vol.3 (6), p.842-848

1985

Volltextzugriff (PDF)

Phase I clinical trial of CX-3543, a pro-apoptotic antitumor agent

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.3082-3082

2006

Volltextzugriff (PDF)

NCCTG phase I/II trial (N9943) of gemcitabine and pemetrexed in patients with biliary tract or gallbladder carcinoma: Phase II results

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.4578-4578

2007

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(52)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(41)
Science & Technology
(41)
Humans
(35)
Biological And Medical Sciences
(25)
Oncology
(24)
Female
(23)
Medical Sciences
(23)
Middle Aged
(20)
Aged
(18)
Adult
(17)
Pharmacology. Drug Treatments
(17)
Male
(16)
Antineoplastic Agents
(14)
Chemotherapy
(13)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(12)
Animals
(8)
Breast Neoplasms - Drug Therapy
(8)
Lung Neoplasms - Drug Therapy
(7)
Random Allocation
(7)
Aged, 80 And Over
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neuroendocrine differentiation is an independent prognostic factor in chemotherapy‐treated nonsmall cell lung carcinoma

The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: Results of a North Central Cancer treatment group Phase III study

Findings from the phase I clinical trials of CX-4945, an orally available inhibitor of CK2

Phase II trial of topotecan for the treatment of mesothelioma

Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trial

Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer

A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancer

Etiologic considerations in superior vena cava syndrome

Treatment of limited-stage small-cell lung cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide: a randomized trial of the North Central Cancer Treatment Group

A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinoma

Phase II study of combined levamisole with recombinant interleukin-2 in patients with advanced malignant melanoma

A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma

Combined levamisole with recombinant interleukin-2 (IL-2) in patients with advanced renal cell carcinoma: A phase II study

Evaluation of intravenous 6-thioguanine as first-line chemotherapy in women with metastatic breast cancer

Advanced Colorectal Adenocarcinoma: Treatment With Amonafide

Prospective phase I evaluation of radiation therapy, 5-fluorouracil, and levamisole in locally advanced gastrointestinal cancer

A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin

Randomized trial of doxorubicin alone or combined with vincristine and mitomycin C in women with metastatic breast cancer

A phase III clinical trial comparing the combination cyclophosphamide, adriamycin, cisplatin with cyclophosphamide, 5-fluorouracil, prednisone in patients with advanced breast cancer

Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast cancer

Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancer

Evaluation of fludarabine phosphate in patients with recurrent glioma

A controlled evaluation of combined 5-fluorouracil, doxorubicin, and mitomycin C (FAM) for the treatment of advanced non-small-cell lung cancer

Phase I clinical trial of CX-3543, a pro-apoptotic antitumor agent

NCCTG phase I/II trial (N9943) of gemcitabine and pemetrexed in patients with biliary tract or gallbladder carcinoma: Phase II results

Suchergebnisse filtern